tiprankstipranks
Trending News
More News >
Pharming Group N.V. (DE:PHGN)
XETRA:PHGN
Germany Market

Pharming Group (PHGN) Financial Statements

Compare
4 Followers

Pharming Group Financial Overview

Pharming Group's market cap is currently €958.82M. The company's EPS TTM is €0.00604219175; its P/E ratio is 408.57; Pharming Group is scheduled to report earnings on March 12, 2026, and the estimated EPS forecast is €<0.01. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue€ 333.28M€ 286.89M€ 245.32M€ 205.62M€ 189.85M
Gross Profit€ 292.97M€ 231.82M€ 220.10M€ 188.06M€ 169.67M
Operating Income€ 17.11M€ -3.39M€ -4.88M€ 18.23M€ 27.84M
EBITDA€ 27.05M€ 13.18M€ 9.88M€ 33.53M€ 48.78M
Net Income€ 2.53M€ -10.64M€ -10.55M€ 13.67M€ 16.00M
Balance Sheet
Cash & Short-Term Investments€ 153.15M€ 162.07M€ 213.42M€ 207.34M€ 191.72M
Total Assets€ 425.70M€ 386.88M€ 462.85M€ 425.80M€ 396.90M
Total Debt€ 98.58M€ 108.42M€ 171.54M€ 166.69M€ 161.59M
Net Debt€ -25.79M€ 55.38M€ 109.80M€ -40.65M€ -30.13M
Total Liabilities€ 189.76M€ 172.72M€ 244.07M€ 221.16M€ 204.19M
Stockholders' Equity€ 277.10M€ 214.16M€ 218.78M€ 204.64M€ 192.72M
Cash Flow
Free Cash Flow€ 43.57M€ -2.50M€ -18.77M€ 20.92M€ 20.17M
Operating Cash Flow€ 44.24M€ -1.73M€ -17.30M€ 22.90M€ 36.13M
Investing Cash Flow€ 16.28M€ 31.62M€ -129.39M€ 5.32M€ -20.34M
Financing Cash Flow€ 12.79M€ -34.41M€ -1.04M€ -4.98M€ -26.68M
Currency in EUR

Pharming Group Earnings and Revenue History

Pharming Group Debt to Assets

Pharming Group Cash Flow

Pharming Group Forecast EPS vs Actual EPS